Insider · CIK 0001378589
Fenton Mary Kay
Reports to the SEC for 4 companies · CAMBRIDGE, MA
Transactions
42
Companies
4
Filings
16
CIK
0001378589
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-30 | CGEMCullinan Therapeutics, Inc.A Award | +$13.3K |
| 2026-02-20 | CGEMCullinan Therapeutics, Inc.S Sale | −$59.9K |
| 2026-02-18 | CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-02-18 | CGEMCullinan Therapeutics, Inc.A Award | — |
| 2025-12-31 | CGEMCullinan Therapeutics, Inc.A Award | +$175.23 |
| 2025-02-19 | CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-19 | CGEMCullinan Therapeutics, Inc.A Award | — |
| 2024-04-29 | CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-07-03 | TRMLTourmaline Bio, Inc.F Tax Payment | −$39.9K |
| 2023-02-01 | TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-02-01 | TRMLTourmaline Bio, Inc. · Stock Appreciation RightA Award | — |
| 2022-09-10 | TRMLTourmaline Bio, Inc.A Award | — |
| 2022-06-23 | Oncorus, Inc.Stock Option (right to buy)A Award | — |
| 2022-02-01 | TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-12-31 | TRMLTourmaline Bio, Inc.A Award | +$13K |
| 2021-06-16 | Oncorus, Inc.Stock Option (right to buy)A Award | — |
| 2018-02-09 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award | — |
| 2017-01-17 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award | — |
| 2016-12-05 | ACHILLION PHARMACEUTICALS INCP Purchase | +$10.3K |
| 2016-01-20 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award | — |
| 2015-12-28 | ACHILLION PHARMACEUTICALS INCS Sale | −$438K |
| 2015-12-28 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionM Exercise/Conversion | — |
| 2015-12-28 | ACHILLION PHARMACEUTICALS INCM Exercise/Conversion | +$45.7K |
| 2015-01-23 | ACHILLION PHARMACEUTICALS INCM Exercise/Conversion | +$52.5K |
| 2015-01-23 | ACHILLION PHARMACEUTICALS INCS Sale | −$210K |
| 2015-01-23 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2014-12-02 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2014-03-04 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2013-12-17 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2012-12-18 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2012-01-10 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2012-01-10 | ACHILLION PHARMACEUTICALS INCS Sale | −$128K |
| 2012-01-10 | ACHILLION PHARMACEUTICALS INCM Exercise/Conversion | +$17K |
| 2012-01-09 | ACHILLION PHARMACEUTICALS INCS Sale | −$40.9K |
| 2011-12-12 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2011-04-06 | ACHILLION PHARMACEUTICALS INCS Sale | −$1,042.5 |
| 2011-04-05 | ACHILLION PHARMACEUTICALS INCS Sale | −$30.8K |
| 2011-03-30 | ACHILLION PHARMACEUTICALS INCS Sale | −$30K |
| 2011-01-13 | ACHILLION PHARMACEUTICALS INCS Sale | −$43.8K |
| 2010-12-16 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2009-12-18 | ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award | — |
| 2006-12-19 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
Recent filings
- 4Fenton Mary Kay0001193125-26-294863SEC(opens sec.gov)
- 4Fenton Mary Kay0001193125-26-064261SEC(opens sec.gov)
- 4Fenton Mary Kay0001193125-26-059637SEC(opens sec.gov)
- 4Fenton Mary Kay0001193125-26-002687SEC(opens sec.gov)
- 4Fenton Mary Kay0000950170-25-025027SEC(opens sec.gov)
- 4Fenton Mary Kay0000950170-24-050844SEC(opens sec.gov)
- 4Fenton Mary Kay0001209191-23-041617SEC(opens sec.gov)
- 4Fenton Mary Kay0001209191-23-006978SEC(opens sec.gov)
- 4Fenton Mary Kay0000899243-22-030928SEC(opens sec.gov)
- 4Fenton Mary Kay0001209191-22-039086SEC(opens sec.gov)
- 4Fenton Mary Kay0000899243-22-004201SEC(opens sec.gov)
- 4Fenton Mary Kay0001209191-21-041617SEC(opens sec.gov)
- 4Fenton Mary Kay0001209191-18-009677SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-17-004606SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-16-153420SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-16-093100SEC(opens sec.gov)
Companies
Address
C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350
CAMBRIDGE, MA, 02142